Your reliable supplier of generic medications.
product caduet is not found!
Sorry we do not carry caduet at this time.
- You can try to search caduet in our product database - CLICK HERE TO SEARCH.
- Fill in the product request form and we will add the requested medicine shortly - PRODUCT REQUEST FORM
Thank you VERY much for your kind email, which explains everything. And for your continued good service, which has - frankly - saved my relationship with the woman I love.
Our billing is certified by:
- Ranbaxy's Net Profit Soars - Wall Street Journal
Wall Street JournalRanbaxy's Net Profit SoarsWall Street JournalThe introduction of the much-awaited Lipitor generic in November, followed by authorized sales of a generic version of Pfizer's Caduet blood-pressure pill, contributed in a big way to Ranbaxy's sales and earnings.
- Ranbaxy Labs - Q1CY12 Result update/ Estimate change - Centrum - Equity Bulls
Ranbaxy Labs - Q1CY12 Result update/ Estimate change - CentrumEquity BullsRLL reported 71%YoY growth in revenues due to FTF opportunities of generic Lipitor and Caduet in the US market.
- Buy Ranbaxy Laboratories; target Rs 559: Emkay - Moneycontrol.com
Moneycontrol.
- Lipitor delivers impressive margins for Ranbaxy - Hindu Business Line
The HinduLipitor delivers impressive margins for RanbaxyHindu Business LineRanbaxy Laboratories' sales growth and high profit margins were helped mainly by sales of Lipitor and Caduet on an exclusive basis in the US.
- Ranbaxy: Positives priced in - Business Standard (blog)
Business LineRanbaxy: Positives priced inBusiness Standard (blog)Sales in the US surged a huge 159 per cent to $410 million in the March quarter, of which Lipitor (a cholesterol lowering drug) and Caduet (a drug prescribed to treat conditions that affect the heart and blood vessels) contributed around $316 million.
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
